Description
CLOPLAK AS Tablets is a crucial combination antiplatelet medication designed to effectively prevent the formation of harmful blood clots, thereby significantly reducing the risk of serious cardiovascular events. Each tablet typically contains Clopidogrel 75mg and Aspirin (Acetylsalicylic Acid) 75mg (or 100mg, depending on formulation). Clopidogrel works by irreversibly inhibiting platelet aggregation, while Aspirin inhibits platelet function through a different mechanism (cyclooxygenase inhibition). This dual antiplatelet therapy (DAPT) provides a synergistic effect, making it highly effective for patients who have experienced a heart attack (myocardial infarction), ischemic stroke, or established peripheral arterial disease. It is also commonly prescribed after certain cardiovascular procedures, such as stent placement, to prevent stent thrombosis. CLOPLAK AS helps maintain proper blood flow to vital organs, safeguarding against recurrent blockages. Strict adherence to dosage and medical supervision are essential due to the increased risk of bleeding. This is a prescription-only medication.
